Filtros de búsqueda

Lista de obras de

A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells

artículo científico publicado en 2016

Association Between MICA Gene Variants and the Risk of Hepatitis C Virus-Induced Hepatocellular Cancer in a Sicilian Population Sample

artículo científico publicado en 2018

Biocompatible Lipid Nanoparticles as Carriers To Improve Curcumin Efficacy in Ovarian Cancer Treatment.

artículo científico publicado en 2017

Cationic Solid Lipid Nanoparticles as Non Viral Vectors for the Inhibition of Hepatocellular Carcinoma Growth by RNA Interference

artículo científico publicado en 2018

GSK-3 in liver diseases: Friend or foe?

artículo científico publicado en 2020

Hepatic and circulating levels of PCSK9 in morbidly obese patients: relation with severity of liver steatosis

scientific article published on 07 August 2020

Lipid nanocarriers containing sorafenib inhibit colonies formation in human hepatocarcinoma cells

artículo científico publicado en 2015

New landscapes and horizons in hepatocellular carcinoma therapy

scientific article published on 04 February 2020

Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generation

artículo científico publicado en 2017

Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma

artículo científico publicado en 2017

Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells

artículo científico publicado en 2018

RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma

scientific article published on 04 November 2019

Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma

scientific article published on 24 December 2018

The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods

scientific article published on 26 April 2020

The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment

artículo científico publicado en 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda